相关实验视频
Updated: Jul 17, 2025

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
502
粉样体和假定的勒维体病理在神经精神病症状中的贡献
Teruyuki Matsuoka1,2, Jin Narumoto1, Fukiko Morii-Kitani3
1Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
International journal of geriatric psychiatry
|September 1, 2023
概括
神经心理症状,如异常感知,可能表明早期痴呆. 这项研究比较了这些症状在临床前阿尔茨海默氏症和前发性帕金森病痴呆症 / 痴呆症与莱维体.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 神经精神症状 (NPSs) 可能是预发性痴呆症的信号.
- 了解临床前阿尔茨海默氏症 (AD) 和前发性帕金森病痴呆症 (PDD) /具有勒维体的痴呆症 (DLB) 之间的NPS差异至关重要.
研究的目的:
- 为了比较临床前/临床前AD中的NPS与临床前PDD/DLB.
主要方法:
- 评估了103名没有痴呆症的参与者 (≥50岁).
- 轻度行为障碍 (MBI) 评分被计算出来.
- 参与者根据粉样蛋白PET和DAT-SPECT扫描进行分组.
主要成果:
- 第1组 (粉样蛋白阳性,异常DAT-SPECT) 显示MBI异常感知/思想内容得分高于对照组 (第5组).
- 第4组 (轻度认知障碍不太可能AD,正常的DAT-SPECT) 的MBI总和冲动失控得分比对照组高.
结论:
- 粉样蛋白和莱维体病理的同时发生可能与精神病症状相关.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
740
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
740
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

